Skip to main content
NATR
NASDAQ Life Sciences

Prescott Group Funds Buy 291,666 NATR Shares for $2.85M in Open Market

Arie Shkolnikov · Analysis by Wiseek AI
More coverage: Food & Beverage Stocks · Consumer
Sentiment info
Positive
Importance info
8
Price
$10.95
Mkt Cap
$190.963M
52W Low
$9.376
52W High
$28.14
52W Position info
17% above low
Off High info
61% below high
Rel. Volume info
1.4× avg
Market data snapshot near publication time

NATR sits 17% above its 52-week low of $9.376.

Summary

Prescott Group's funds bought 291,666 NATR shares for $2.85 million at $9.50-$9.95 on 2026-11-05, raising their stake to 2,236,152 shares — a much larger buy than their August purchase and made just after weak Q3 results and a guidance cut.


Key Events · Ownership and Investor Activity · NATR

  • Prescott Funds Add 291,666 Shares

    Five Prescott Group reporting entities bought 291,666 shares for $2,849,810.84 across 20 open-market trades on 2026-11-05, at prices from $9.50 to $9.95.

  • Stake Rises to 2,236,152 Shares

    Post-transaction indirect holdings reached 2,236,152 shares, held through the Master Fund for the accounts of the two Small Cap funds.

  • Buy Follows Weak Q3 and Guidance Cut

    The purchase came one day after the 2026-11-04 8-K reporting Q3 sales down 9% to $116.6 million, EPS of $0.11 versus $0.30, and a cut to full-year sales guidance.

  • Far Larger Than August Purchase

    The 2026-08-19 Form 4 reported 20,000 shares bought for $293,800; this buy is about ten times that dollar amount and roughly 1.5% of market cap.


Analysis · NATR · Life Sciences

Phil Frohlich's Prescott Group funds bought 291,666 shares for $2,849,810.84 at $9.50-$9.95 on 2026-11-05, lifting their combined stake to 2,236,152 shares. This is a genuine open-market purchase, not an option exercise or grant, and it is roughly ten times the size of the 20,000-share buy the same group reported on 2026-08-19. The buying came in the days right after Q3 results showed sales down 9% to $116.6 million and management cut full-year sales guidance, so the fund was adding while the stock was under pressure. One caveat: this is a financial 10% owner, not an operator, so the read-through is conviction in valuation rather than a view on day-to-day execution.

How filings like this one have moved

In the 30 days to Nov 9, 2026, 47.1% of the 1533 measured filings Wiseek scored 8 moved their stock by 5% or more by the next session's close. The median move was -0.29%. These are measured outcomes after filings of this importance, not a forecast for this one.

Measured one observation per ticker per day, after exclusions. Current figures: Filing Impact Tracker · open dataset

At the time of this filing, NATR was trading at $10.95 on NASDAQ in the Life Sciences sector, with a market capitalization of approximately $191M. The 52-week trading range was $9.38 to $28.14. This filing was assessed with positive market sentiment and an importance score of 8 out of 10.

View Main SEC Filing

Price Chart

Share this article

Copied!

NATR - Latest Insights

NATR
Nov 04, 2026, 5:27 PM EST
Filing Type: 8-K
Importance Score:
8
Price at Filing: $10.80
Real-time Price: $11.25 info
Change: +$0.450 (+4%) info
Market Cap: $190.963M info
NATR
Nov 04, 2026, 4:05 PM EST
Source: GlobeNewswire
Importance Score:
8
Price at Filing: $11.55
Real-time Price: $11.25 info
Change: -$0.300 (-3%) info
Market Cap: $190.963M info
NATR
Aug 10, 2026, 7:15 PM EDT
Filing Type: 4
Importance Score:
7
Price at Filing: $15.77
Real-time Price: $11.25 info
Change: -$4.52 (-29%) info
Market Cap: $190.963M info
NATR
Aug 06, 2026, 5:15 PM EDT
Filing Type: 10-Q
Importance Score:
7
Price at Filing: $17.95
Real-time Price: $11.25 info
Change: -$6.70 (-37%) info
Market Cap: $190.963M info
NATR
Aug 06, 2026, 4:35 PM EDT
Filing Type: 8-K
Importance Score:
8
Price at Filing: $16.40
Real-time Price: $11.25 info
Change: -$5.15 (-31%) info
Market Cap: $190.963M info